NfL is released into CSF upon axonal damage and seems to be an unspecific marker as it is increased in AD and MCI [6], but also in other neurodegenerative conditions [8–10], and is associated with increased risk of progression to AD and worsening cognition [11]. This evidence concerns the gene NEFL and Alzheimer disease.